PAM-Free Targeting
About Procedure
Audire feugiat nostrum mea et, quo fabulas adipisci intellegat in. Ei cum errem platonem, noster scribentur ne vim. Est torquatos dissentias ex. Et est labore fierent postulant, pro in oportere deseruisse. Mea at dico erant denique, pro aeque maluisset te, an eum omnes postea.
Price
$25.00Time
1hEquipments
Sharp Blade
GERNA’s Cas-free gene editing platform eliminates the need for a protospacer-adjacent motif (PAM), unlocking targets across the genome that conventional CRISPR systems cannot reach. This PAM-free targeting provides far greater flexibility, enabling therapeutic editing of mutations previously deemed “uneditable” and thereby expanding our pipeline to more diseases.
Mea eros labore bonorum et, ad vim pertinacia consetetur, idque mnesarchum ne per. Debitis efficiantur delicatissimi in his, munere adipiscing voluptatibus eam an, doming neglegentur theophrastus eu nam. Mel probatus facilisis aliquando ea, adhuc accusam intellegat cu vel.
Book an Appointment
Suspendisse aliquet fringilla libero ac suscipit. Praesent porttitor sodales justo, nec sagittis odio congue id